PICHLER, M., V. STIEGELBAUER, Petra VYCHYTILOVÁ, C. IVAN, H. LING, E. WINTER, X.N. ZHANG, M. GOBLIRSCH, A. WULF-GOLDENBERG, M. OHTSUKA, J. HAYBAECK, M. SVOBODA, Y. OKUGAWA, A. GERGER, G. HOEFLER, A. GOEL, Ondřej SLABÝ and G.A. CALIN. Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis. Clinical cancer research. Philadelphia: AMER ASSOC CANCER RESEARCH, 2017, vol. 23, No 5, p. 1323-1333. ISSN 1078-0432. Available from: https://dx.doi.org/10.1158/1078-0432.CCR-16-0497.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis
Authors PICHLER, M. (40 Austria), V. STIEGELBAUER (40 Austria), Petra VYCHYTILOVÁ (203 Czech Republic, belonging to the institution), C. IVAN (40 Austria), H. LING (40 Austria), E. WINTER (40 Austria), X.N. ZHANG (840 United States of America), M. GOBLIRSCH (40 Austria), A. WULF-GOLDENBERG (276 Germany), M. OHTSUKA (840 United States of America), J. HAYBAECK (840 United States of America), M. SVOBODA (203 Czech Republic), Y. OKUGAWA (840 United States of America), A. GERGER (840 United States of America), G. HOEFLER (40 Austria), A. GOEL (840 United States of America), Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution) and G.A. CALIN (840 United States of America).
Edition Clinical cancer research, Philadelphia, AMER ASSOC CANCER RESEARCH, 2017, 1078-0432.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 10.199
RIV identification code RIV/00216224:14740/17:00100443
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1158/1078-0432.CCR-16-0497
UT WoS 000396015600023
Keywords in English ANTI-EGFR THERAPY; TUMOR-GROWTH; COLON-CANCER; MICRORNA SIGNATURES; PREDICTIVE-VALUE; STAGE-II; METASTASIS; EXPRESSION; PROGRESSION; BIOMARKER
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 26/4/2021 13:41.
Abstract
Purpose: Characterization of colorectal cancer transcriptome by high-throughput techniques has enabled the discovery of several differentially expressed genes involving previously unreported miRNA abnormalities. Here, we followed a systematic approach on a global scale to identify miRNAs as clinical outcome predictors and further validated them in the clinical and experimental setting. Experimental Design: Genome-wide miRNA sequencing data of 228 colorectal cancer patients from The Cancer Genome Atlas dataset were analyzed as a screening cohort to identify miRNAs significantly associated with survival according to stringent pre-specified criteria. A panel of six miRNAs was further validated for their prognostic utility in a large independent validation cohort (n = 332). In situ hybridization and functional experiments in a panel of colorectal cancer cell lines and xenografts further clarified the role of clinical relevant miRNAs. Results: SixmiRNAs (miR-92b-3p, miR-188-3p, miR-221-5p, miR-331-3p, miR-425-3p, and miR-497-5p) were identified as strong predictors of survival in the screening cohort. High miR-188-3p expression proves to be an independent prognostic factor [screening cohort: HR = 4.137; 95% confidence interval (CI), 1.568-10.917; P = 0.004; validation cohort: HR = 1.538; 95% CI, 1.107-2.137; P = 0.010, respectively]. Forced miR-188-3p expression increased migratory behavior of colorectal cancer cells in vitro and metastases formation in vivo (P < 0.05). The promigratory role of miR-188-3p is mediated by direct interaction with MLLT4, a novel identified player involved in colorectal cancer cell migration. Conclusions: miR-188-3p is a novel independent prognostic factor in colorectal cancer patients, which can be partly explained by its effect on MLLT4 expression and migration of cancer cells. (C) 2016 AACR.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
90004, large research infrastructuresName: BBMRI-CZ
PrintDisplayed: 13/10/2024 08:33